Articles related to Cardiology

In this JAMA Oncology Narrative Review, the authors attempt to discover whether cardiovascular risks may be associated with the multimodal approach, including systemic therapies and breast radiotherapy (RT), in treating breast cancer patients. Although recent advancements in breast cancer treatment have led to a decrease in mortality rates, the prevalence of survivors with a potentially high CV disease risk has increased.

The data was presented to the FDA, which reported 789 cases of myocarditis/pericarditis – predominantly in males – after receiving the Pfizer/BioNTech and Moderna vaccines, most commonly after the second dose. Symptoms included chest pain, elevated cardiac enzymes, ST or T wave changes, dyspnea, and abnormal echocardiography/imaging for those ages 30 years and younger.

The action comes after observational evidence associating the HeartWare left ventricular assist device (LVAD) with increased neurological adverse events and mortality, as well as more than 100 complaints involving delay or failure to restart. First approved in November 2012, the LVAD has been implanted in approximately 2,000 US patients experiencing end-stage heart failure.

The DASH diet is not a new fad or trend in wellness; it’s a lifelong approach to healthy eating, developed to lower blood pressure without medication. DASH – Dietary Approaches to Stop Hypertension – is all about limiting sodium in your diet while encouraging the intake of potassium, calcium, and magnesium – nutrients that help lower blood pressure. A valuable resource to share with your patients!

Are you biased toward certain types of patients? “Sometimes” is likely your answer, but there are implicit biases that doctors may not be aware they have. To help answer this question, Medscape put together a survey to weigh these biases, with emotional problems coming in at No. 1. Whether they are implicit or explicit, here are the other patient characteristics that commonly trigger a predisposition in doctors. 

Since April 2021, there have been reports of myocarditis and/or pericarditis after receipt of an m-RNA COVID-19 vaccine, according to the Centers for Disease Control and Prevention (CDC) . Most cases have been among male adolescents and young adults ages 16 and older, typically occurring within several days after the second dose of m-RNA COVID-19 vaccine.